| Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus … NJ Mercuro, CF Yen, DJ Shim, TR Maher, CM McCoy, PJ Zimetbaum, ... JAMA cardiology 5 (9), 1036-1041, 2020 | 860 | 2020 |
| Delafloxacin: place in therapy and review of microbiologic, clinical and pharmacologic properties SCJ Jorgensen, NJ Mercuro, SL Davis, MJ Rybak Infectious Diseases and Therapy 7, 197-217, 2018 | 100 | 2018 |
| Combatting resistant enterococcal infections: a pharmacotherapy review NJ Mercuro, SL Davis, MJ Zervos, ES Herc Expert opinion on pharmacotherapy 19 (9), 979-992, 2018 | 78 | 2018 |
| Retrospective analysis comparing oral stepdown therapy for Enterobacteriaceae bloodstream infections: fluoroquinolones versus β-lactams NJ Mercuro, P Stogsdill, M Wungwattana International journal of antimicrobial agents 51 (5), 687-692, 2018 | 66 | 2018 |
| Early multicenter experience with imipenem-cilastatin-relebactam for multidrug-resistant gram-negative infections N Rebold, T Morrisette, AM Lagnf, S Alosaimy, D Holger, K Barber, ... Open Forum Infectious Diseases 8 (12), ofab554, 2021 | 30 | 2021 |
| Pharmacist-driven transitions of care practice model for prescribing oral antimicrobials at hospital discharge NJ Mercuro, CJ Medler, RM Kenney, NC MacDonald, MM Neuhauser, ... JAMA network open 5 (5), e2211331-e2211331, 2022 | 27 | 2022 |
| Clinical utility of lefamulin: if not now, when? NJ Mercuro, MP Veve Current infectious disease reports 22, 1-13, 2020 | 23 | 2020 |
| Prevalence and Predictors of Pseudomonas aeruginosa Among Hospitalized Patients With Diabetic Foot Infections MP Veve, NJ Mercuro, RJ Sangiovanni, M Santarossa, N Patel Open forum infectious diseases 9 (7), ofac297, 2022 | 20 | 2022 |
| Stewardship opportunities in viral pneumonia: why not the immunocompromised? NJ Mercuro, RM Kenney, L Samuel, RJ Tibbetts, GJ Alangaden, SL Davis Transplant Infectious Disease 20 (2), e12854, 2018 | 18 | 2018 |
| Uncomplicated streptococcal bacteremia: the era of oral antibiotic step-down therapy? R Waked, WY Craig, NJ Mercuro, M Wungwattana, E Wood, KE Rokas International journal of antimicrobial agents 61 (3), 106736, 2023 | 12 | 2023 |
| It is time to define antimicrobial never events J Liu, KS Kaye, NJ Mercuro, SL Davis, TS Patel, LA Petty, GM Pais, ... Infection Control & Hospital Epidemiology 40 (2), 206-207, 2019 | 12 | 2019 |
| Improving care for critically ill patients with community-acquired pneumonia ML Bianchini, NJ Mercuro, RM Kenney, MA Peters, LP Samuel, ... American journal of health-system pharmacy 76 (12), 861-868, 2019 | 10 | 2019 |
| Outcomes associated with empiric cefepime for bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Escherichia coli and Klebsiella pneumoniae BE Frescas, CM McCoy, J Kirby, R Bowden, NJ Mercuro International Journal of Antimicrobial Agents 61 (5), 106762, 2023 | 6 | 2023 |
| Ambulatory quinolone prescribing: moving from opportunity to implementation NJ Mercuro, RM Kenney, O Abreu-Lanfranco, SL Davis Clinical Infectious Diseases 67 (8), 1306-1307, 2018 | 6 | 2018 |
| Pharmacokinetics of cefazolin in patients with obesity undergoing surgery requiring cardiopulmonary bypass J Poltak, C Connors, M Wungwattana, D Nicolau, NJ Mercuro, J Liu Journal of cardiothoracic and vascular anesthesia 36 (8), 2942-2947, 2022 | 5 | 2022 |
| Treatment and outcomes of Enterococcus faecium bloodstream infections in solid organ transplant recipients NJ Mercuro, CM Gill, RM Kenney, GJ Alangaden, SL Davis Transplant Infectious Disease 22 (2), e13251, 2020 | 5 | 2020 |
| Fluoroquinolone prescribing for diabetic foot infections following an FDA drug safety communication for aortic aneurysm risk C Li, NJ Mercuro, RW Chapin, HS Gold, C McCoy Antimicrobial Agents and Chemotherapy 65 (9), 10.1128/aac. 00708-21, 2021 | 4 | 2021 |
| Improving prescribing practices at hospital discharge with pharmacist-led antimicrobial stewardship at transitions of care N Mercuro, C Medler, N MacDonald, R Kenney, M Neuhauser, L Hicks, ... Infection Control & Hospital Epidemiology 41 (S1), s289-s290, 2020 | 4 | 2020 |
| Case report: Successful treatment of OXA-23 Acinetobacter baumannii neurosurgical infection and meningitis with sulbactam-durlobactam combination therapy JW Snowdin, NJ Mercuro, MP Madaio, SA Rawlings Frontiers in Medicine 11, 1381123, 2024 | 2 | 2024 |
| Predictors of discordant MRSA nares and respiratory cultures in patients with pneumonia NP Palisano, CF Yen, NJ Mercuro JAC-antimicrobial resistance 4 (5), dlac095, 2022 | 2 | 2022 |
